Maze Therapeutics, Inc. Common Stock (MAZE) — Defensive Interval Ratio
Maze Therapeutics, Inc. Common Stock (MAZE) has a Defensive Interval Ratio of 3358 days as of June 2026. Defensive assets of $211.24 Million (cash $-, short-term investments $208.44 Million, receivables $2.80 Million) cover 3358 days of daily cash needs of $62.91K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Maze Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Maze Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 3358 days, meaning defensive assets of $211.24 Million can fund 3358 days of operations without new revenue. For the complete balance sheet picture, see MAZE asset base.
Annual Defensive Interval Ratio for Maze Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Maze Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See MAZE net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2495 days | $154.17 Million | $61.80K/day | $- | $152.67 Million | ▲ +2495 days |
| 2024 | 0 days | $0.00 | $56.64K/day | $- | $0.00 | — |